Attached files

file filename
10-Q - FORM 10-Q - PharMerica CORPd10q.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER ADOPTED PURSUANT TO SECTION 302 - PharMerica CORPdex311.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER ADOPTED PURSUANT TO SECTION 906 - PharMerica CORPdex322.htm
EX-10.57 - AMENDED AND RESTATED PHARMERICA CORPORATION 2007 OMNIBUS INCENTIVE PLAN - PharMerica CORPdex1057.htm
EX-10.58 - FORM OF DIRECTOR RESTRICTED STOCK UNIT AWARD AGREEMENT - PharMerica CORPdex1058.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER ADOPTED PURSUANT TO SECTION 302 - PharMerica CORPdex312.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PharMerica Corporation (the “Corporation”) on Form 10-Q for the quarter ended June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregory S. Weishar, Chief Executive Officer and Director of the Corporation, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition, and results of operations of the Corporation.

 

/s/    GREGORY S. WEISHAR

Gregory S. Weishar

Chief Executive Officer and Director

August 5, 2010